Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Predicting response to immunotherapy in gastric cancer via assessing perineural invasion-mediated inflammation in tumor microenvironment. | J Exp Clin Cancer Res | 2023 | 37563649 | PubTator, text mining | PubMed |
| Development of a scoring system for predicting primary resistance to venetoclax plus hypomethylating agents (HMAs) in acute myeloid leukemia patients. | Mol Carcinog | 2023 | 37555764 | PubTator, text mining | PubMed |
| BET in hematologic tumors: Immunity, pathogenesis, clinical trials and drug combinations. | Genes Dis | 2023 | 37554207 | PubTator, text mining | PubMed |
| Studies on the fat mass and obesity-associated (FTO) gene and its impact on obesity-associated diseases. | Genes Dis | 2023 | 37554175 | PubTator, text mining | PubMed |
| Disseminated non-tuberculous mycobacterial infection caused by Mycobacterium obuense in an immunocompromised patient: a case report. | BMC Infect Dis | 2023 | 37550642 | PubTator, text mining | PubMed |
| [Retrospective analysis of the efficacy and safety of Venetoclax-based regimen in the treatment of 12 cases of acute myeloid leukemia with t (8; 21)]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37550208 | PubTator, text mining | PubMed |
| [Establishment of leukemia cell model with inducible AML1-ETO expression and its effect on fatty acid metabolism in leukemia cells]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37550185 | PubTator, text mining | PubMed |
| Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment. | Front Cell Dev Biol | 2023 | 37538397 | PubTator, text mining | PubMed |
| Identification of DUSP7 as an RNA Marker for Prognostic Stratification in Acute Myeloid Leukemia: Evidence from Large Population Cohorts. | Genet Res (Camb) | 2023 | 37538139 | PubTator, text mining | PubMed |
| CARM1 arginine methyltransferase as a therapeutic target for cancer. | J Biol Chem | 2023 | 37536629 | PubTator, text mining | PubMed |
| Twenty-four-color full spectrum flow cytometry panel for minimal residual disease detection in acute myeloid leukemia. | Open Med (Wars) | 2023 | 37533738 | PubTator, text mining | PubMed |
| Homoharringtonine-Based Induction Regimen Improved the Remission Rate and Survival Rate in Chinese Childhood AML: A Report From the CCLG-AML 2015 Protocol Study. | J Clin Oncol | 2023 | 37531592 | PubTator, text mining | PubMed |
| Hemophagocytic Lymphohistiocytosis in RUNX1::RUNX1T1 Positive AML with Blast Count Below 20% | Turk J Haematol | 2023 | 37519108 | PubTator, text mining | PubMed |
| The Effects of Green Tea Catechins in Hematological Malignancies. | Pharmaceuticals (Basel) | 2023 | 37513933 | PubTator, text mining | PubMed |
| Current Landscape of Genome-Wide Association Studies in Acute Myeloid Leukemia: A Review. | Cancers (Basel) | 2023 | 37509244 | PubTator, text mining | PubMed |
| The Promise of Retinoids in the Treatment of Cancer: Neither Burnt Out Nor Fading Away. | Cancers (Basel) | 2023 | 37509198 | PubTator, text mining | PubMed |
| PARP10 is highly expressed and associated with inferior outcomes in acute myeloid leukemia. | Aging (Albany NY) | 2023 | 37506247 | PubTator, text mining | PubMed |
| Chemotherapy Regimens for Non-Metastatic Conventional Appendicular Osteosarcoma: A Literature Review Based on the Outcomes. | Curr Oncol | 2023 | 37504317 | PubTator, text mining | PubMed |
| Peer review of the pesticide risk assessment of the active substance glyphosate. | EFSA J | 2023 | 37502013 | PubTator, text mining | PubMed |
| An overview of arsenic trioxide-involved combined treatment algorithms for leukemia: basic concepts and clinical implications. | Cell Death Discov | 2023 | 37500645 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=14